PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Gramicidin→

Gramicidin PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
1405-97-6
Molecular formula
Not available
Molecular weight
~1800 g/mol
Drug class
Polypeptide antibiotictopical membrane-disrupting antibacterial
Mechanism of action
Gramicidin inserts into bacterial lipid bilayers and forms transmembrane channels that increase permeability to monovalent cations, disrupting ionic gradients and membrane function. It is active mainly against Gram-positive bacteria.
Indications / reported uses
  • Topical treatment of susceptible local bacterial infections in skin, eye or ear preparations where gramicidin-containing products are authorised; ophthalmic products are commonly used in combination with other anti-infectives.

Sources: https://www.xellia.com/products/api-products/gramicidin · https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=9691178e-5323-40ce-a8b3-f79e88f02797&type=display

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Gramicidin PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Gramicidin Permitted Daily Exposure (PDE) report (the Gramicidin PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Gramicidin Occupational Exposure Limit (OEL) report (the Gramicidin OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.